Related Experiment Video
Updated: Mar 11, 2026

08:52
Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
Published on: February 17, 2015
10.2K
Gene Delivery for the Generation of Bioartificial Pacemaker
Patrick K W Chan1, Ronald A Li2,3,4
1Stem Cell & Regenerative Medicine Consortium, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong.
Methods in Molecular Biology (Clifton, N.J.)
|December 3, 2016
Summary
Researchers developed a bioartificial pacemaker using gene transfer to convert heart muscle cells into pacemaker cells. This innovative approach addresses limitations of traditional electronic pacemakers, offering a potential new therapy for heart rhythm disorders.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Biomedical Engineering
Background:
- Electronic pacemakers are standard for heart rhythm disorders but have drawbacks like limited battery life and implantation risks.
- Existing devices lack natural autonomic responses, impacting overall cardiovascular regulation.
- Lead dislodging and catheter-related complications are significant concerns with current pacemaker technology.
Purpose of the Study:
- To establish reliable porcine models for studying sick sinus syndrome and complete heart block.
- To engineer a bioartificial pacemaker using somatic gene transfer.
- To convert cardiomyocytes into functional, rhythmically firing pacemaker-like cells.
Main Methods:
- Development of porcine models mimicking human heart rhythm disorders.
- Strategic engineering of hyperpolarization-activated cyclic nucleotide-gated pacemaker channel protein.
- Somatic gene transfer to deliver the engineered channel protein into cardiomyocytes.
Main Results:
- Successful establishment of porcine models for sick sinus syndrome and complete heart block.
- Demonstration of cardiomyocyte conversion into nodal-like cells capable of rhythmic electrical activity.
- Generation of a bioartificial pacemaker system through genetic modification.
Conclusions:
- Bioartificial pacemakers offer a promising alternative to electronic devices.
- Somatic gene transfer can effectively reprogram cardiomyocytes for pacemaker function.
- This approach may overcome limitations associated with traditional pacemaker implantation and function.

